Title 22 — Foreign Relations and Intercourse
Part A · Chapter 83 — United States Leadership Against Hiv/aids, Tuberculosis, and Malaria
§ 7631a. United States Agency for International Development
Statutory text
In general
The Administrator of the United States Agency for International Development, in coordination with the Coordinator of United States Government Activities to Combat HIV/AIDS Globally, may facilitate availability and accessibility of microbicides, provided that such pharmaceuticals are approved, tentatively approved, or otherwise authorized for use by—
the Food and Drug Administration;
a stringent regulatory agency acceptable to the Secretary of Health and Human Services; or
a quality assurance mechanism acceptable to the Secretary of Health and Human Services.
Authorization of appropriations
Of the amounts authorized to be appropriated under section 7671 of this title for HIV/AIDS assistance, there are authorized to be appropriated to the President such sums as may be necessary for each of the fiscal years 2009 through 2013 to carry out this section.
Legislative history
Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Pub. L. 110–293 title II § 203(e) · 122 Stat. 2918
Enacted · 22 U.S.C. § 7631a
(Pub. L. 110–293, title II, § 203(e), July 30, 2008, 122 Stat. 2941.)
Source evidence
Code source credit
(Pub. L. 110–293, title II, § 203(e), July 30, 2008, 122 Stat. 2941.)Enacted provision · exact public law section
(e) United States Agency for International Development.— (1) In general.— The Administrator of the United States Agency for International Development, in coordination with the Coordinator of United States Government Activities to Combat HIV/AIDS Globally, may facilitate availability and accessibility of microbicides, provided that such pharmaceuticals are approved, tentatively approved, or otherwise authorized for use by— (A) the Food and Drug Administration; (B) a stringent regulatory agency acceptable to the Secretary of Health and Human Services; or (C) a quality assurance mechanism acceptable to the Secretary of Health and Human Services. (2) Authorization of appropriations.— Of the amounts authorized to be appropriated under section 401 of the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 (22 U.S.C. 7671) for HIV/AIDS assistance, there are authorized to be appropriated to the President such sums as may be necessary for each of the fiscal years 2009 through 2013 to carry out this subsection.
1 of 1 references resolved to an enrolled provision
Editorial Notes
Codification
Section was enacted as part of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, and not as part of the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 which comprises this chapter.